Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation
Annals of Hematology · 10.11.2026
DOI: 10.1007/s00277-026-07341-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 10.11.2026. Verfasst von Luxin Zhang und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Subject Excellent Reserve Talent Project, Clinical Key Specialty Project of Guizhou Province, Clinical Medicine Research Center of Guizhou Province.
Abstract (Originalsprache)
After allogeneic hematopoietic stem cell transplantation (allo-HSCT), some patients continue to have severe anemia despite neutrophil and platelet engraftment, and persistent poor erythroid recovery often leaves them dependent on red blood cell transfusion. Management in this setting remains difficult. To examine the clinical activity of luspatercept in patients with anemia related to poor erythroid engraftment after allo-HSCT, focusing on hemoglobin (Hb) recovery, transfusion outcomes, and changes in bone marrow erythropoiesis. We retrospectively reviewed 12 patients treated at our center between January 2023 and December 2025 for anemia related to poor erythroid engraftment after allo-HSCT. All had achieved myeloid and megakaryocytic engraftment and complete donor chimerism confirmed by short tandem repeat analysis, but their peripheral blood Hb remained
Förderung
- the Subject Excellent Reserve Talent Project
- Clinical Key Specialty Project of Guizhou Province
- Clinical Medicine Research Center of Guizhou Province
- the Foundation of Hematology Specialization
- Natural Science Foundation of Guizhou Province
Zitieren
APA
Zhang, L., Li, S., Wang, F., Zhan, Y., Cheng, W., Zhao, M., Zhao, P., Xu, W., Huang, Y., Yang, X., Zhang, T., Li, Y., Liu, Y., & Zhu, H. (2026). Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation. Annals of Hematology. https://doi.org/10.1007/s00277-026-07341-1
Vancouver
Zhang L, Li S, Wang F, Zhan Y, Cheng W, Zhao M, et al. Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 2026. doi:10.1007/s00277-026-07341-1
BibTeX
@article{Zhang2026,
author = {Zhang, Luxin and Li, Shaoyue and Wang, Feiqing and Zhan, Yun and Cheng, Weiwei and Zhao, Mei and Zhao, Peng and Xu, Wen and Huang, Yi and Yang, Xueying and Zhang, Tianzhuo and Li, Yanju and Liu, Yang and Zhu, Hongqian},
title = {Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation},
journal = {Annals of Hematology},
year = {2026},
doi = {10.1007/s00277-026-07341-1}
}
EUVIMED